Skip to main content
Top
Published in: Digestive Diseases and Sciences 4/2008

01-04-2008 | Original Paper

Effect of a Gluten-free Diet on the Risk of Enteropathy-associated T-cell Lymphoma in Celiac Disease

Authors: Marco Silano, Umberto Volta, Alessandro De Vincenzi, Mariarita Dessì, Massimo De Vincenzi, The Collaborating Centers of the Italian Registry of the Complications of Coeliac Disease

Published in: Digestive Diseases and Sciences | Issue 4/2008

Login to get access

Abstract

Patients with celiac disease have an increased rate of enteropathy-associated T-cell lymphoma, but conflicting data are available about the protective role of a gluten-free diet with regard to the development of this malignancy. We followed 1,757 celiac patients for a total period of 31,801 person-years, collecting data about the frequency of gluten intake and the incidence of the enteropathy-associated T-cell lymphoma. Out of the nine celiac patients who developed an intestinal lymphoma [standard morbidity ratio of 6.42 (95% CI = 2.9–12.2; P < 0.001)], only two kept a strict gluten-free diet after the diagnosis of celiac diasese and developed the malignancy after the peridiagnosis period of 3 years, dropping therefore the standard morbidity ratio to 0.22 (95%CI = 0.02–0.88; P < 0.001). The risk of developing an intestinal lymphoma for the celiac patients that used to have dietary gluten was significant (X= 4.8 P = 0.01). These results show that a strict gluten-free diet is protective towards the development of enteropathy-associated T-cell lymphoma.
Literature
1.
go back to reference O’Farrelly C, Feighery C, O’Briain DS, Stevens F, Connolly CE, McCarthy C, Weir DG (1986) Humoral response to wheat protein in patients with coeliac disease and enteropathy-associated T-cell lymphoma. Br Med J 293:908–910CrossRef O’Farrelly C, Feighery C, O’Briain DS, Stevens F, Connolly CE, McCarthy C, Weir DG (1986) Humoral response to wheat protein in patients with coeliac disease and enteropathy-associated T-cell lymphoma. Br Med J 293:908–910CrossRef
2.
go back to reference Howdle PD, Jalal PK, Holmes GK, Houlston RS (2003) Primary small-bowel malignancy in the UK and its association with coeliac disease. QJM 96:345–353PubMedCrossRef Howdle PD, Jalal PK, Holmes GK, Houlston RS (2003) Primary small-bowel malignancy in the UK and its association with coeliac disease. QJM 96:345–353PubMedCrossRef
3.
go back to reference Brousse N, Meijer JW (2005) Malignant complications of coeliac disease. Best Pract Res Clin Gastroenterol 19:401–412PubMedCrossRef Brousse N, Meijer JW (2005) Malignant complications of coeliac disease. Best Pract Res Clin Gastroenterol 19:401–412PubMedCrossRef
4.
go back to reference Meijer JW, Mulder CJ, Goerres MG, Boot H, Schweizer JJ (2004) Coeliac disease and (extra)intestinal T-cell lymphomas: definition, diagnosis and treatment. Scand J Gastroenterol 241:78–84CrossRef Meijer JW, Mulder CJ, Goerres MG, Boot H, Schweizer JJ (2004) Coeliac disease and (extra)intestinal T-cell lymphomas: definition, diagnosis and treatment. Scand J Gastroenterol 241:78–84CrossRef
5.
go back to reference Catassi C, Fabiani E, Corrao G, Barbato M, De Renzo A, Carella AM, Gabrielli A, Leoni P, Carroccio A, Baldassarre M, Bertolani P, Caramaschi P, Sozzi M, Guariso G, Volta U, Corazza GR (2002) Italian Working Group on Coeliac Disease and Non-Hodgkin’s-Lymphoma. Risk of non-Hodgkin lymphoma in celiac disease. JAMA 287:1413–1419PubMedCrossRef Catassi C, Fabiani E, Corrao G, Barbato M, De Renzo A, Carella AM, Gabrielli A, Leoni P, Carroccio A, Baldassarre M, Bertolani P, Caramaschi P, Sozzi M, Guariso G, Volta U, Corazza GR (2002) Italian Working Group on Coeliac Disease and Non-Hodgkin’s-Lymphoma. Risk of non-Hodgkin lymphoma in celiac disease. JAMA 287:1413–1419PubMedCrossRef
6.
go back to reference West J, Logan RF, Smith CJ, Hubbard RB, Card TR (2004) Malignancy and mortality in people with coeliac disease: population-based cohort study. BMJ 329:716–719PubMedCrossRef West J, Logan RF, Smith CJ, Hubbard RB, Card TR (2004) Malignancy and mortality in people with coeliac disease: population-based cohort study. BMJ 329:716–719PubMedCrossRef
7.
go back to reference Holmes GK, Prior P, Lane MR, Pope D, Allan RN (1989) Malignancy in coeliac disease-effect of a gluten-free diet. Gut 30:333–338PubMedCrossRef Holmes GK, Prior P, Lane MR, Pope D, Allan RN (1989) Malignancy in coeliac disease-effect of a gluten-free diet. Gut 30:333–338PubMedCrossRef
8.
go back to reference Collin P, Reunala T, Pukkala E, Laippala P, Keyrilainen O, Pasternack A (1994) Coeliac disease: associated disorders and survival. Gut 35:1215–1218PubMedCrossRef Collin P, Reunala T, Pukkala E, Laippala P, Keyrilainen O, Pasternack A (1994) Coeliac disease: associated disorders and survival. Gut 35:1215–1218PubMedCrossRef
9.
go back to reference Askling J, Linet M, Gridley G, Halstensen TS, Ekstrom K, Ekbom A (2002) Cancer incidence in a population-based cohort of individuals hospitalized with celiac disease or dermatitis herpetiformis. Gastroenterology 123:1428–1435PubMedCrossRef Askling J, Linet M, Gridley G, Halstensen TS, Ekstrom K, Ekbom A (2002) Cancer incidence in a population-based cohort of individuals hospitalized with celiac disease or dermatitis herpetiformis. Gastroenterology 123:1428–1435PubMedCrossRef
10.
go back to reference Silano M, Volta U, Mecchia AM, Dessi M, Di Benedetto R, De Vincenzi M, Collaborating centers of the Italian registry of the complications of coeliac disease (2007) Delayed diagnosis of coeliac disease increases cancer risk. BMC Gastroenterol 9:8CrossRef Silano M, Volta U, Mecchia AM, Dessi M, Di Benedetto R, De Vincenzi M, Collaborating centers of the Italian registry of the complications of coeliac disease (2007) Delayed diagnosis of coeliac disease increases cancer risk. BMC Gastroenterol 9:8CrossRef
11.
12.
go back to reference Green PH, Fleischauer AT, Bhagat G, Goyal R, Jabri B, Neugut AI (2003) Risk of malignancy in patients with celiac disease. Am J Med 115:191–195PubMedCrossRef Green PH, Fleischauer AT, Bhagat G, Goyal R, Jabri B, Neugut AI (2003) Risk of malignancy in patients with celiac disease. Am J Med 115:191–195PubMedCrossRef
13.
go back to reference Peters U, Askling J, Gridley G, Ekbom A, Linet M (2003) Causes of death in patients with celiac disease in a population-based Swedish cohort. Arch Intern Med 163:1566–1572PubMedCrossRef Peters U, Askling J, Gridley G, Ekbom A, Linet M (2003) Causes of death in patients with celiac disease in a population-based Swedish cohort. Arch Intern Med 163:1566–1572PubMedCrossRef
14.
go back to reference Catassi C, Bearzi I, Holmes GK (2005) Association of celiac disease and intestinal lymphomas and other cancers. Gastroenterology 128:S79–S86PubMedCrossRef Catassi C, Bearzi I, Holmes GK (2005) Association of celiac disease and intestinal lymphomas and other cancers. Gastroenterology 128:S79–S86PubMedCrossRef
15.
go back to reference Martin-Pagola A, Ortiz-Paranza L, Bilbao JR, de Nanclares GP, Estevez EP, Castano L, Vitoria JC (2007) Two-year follow-up of anti-transglutaminase autoantibodies among celiac children on gluten-free diet: comparison of IgG and IgA. Autoimmunity 40:117–121PubMedCrossRef Martin-Pagola A, Ortiz-Paranza L, Bilbao JR, de Nanclares GP, Estevez EP, Castano L, Vitoria JC (2007) Two-year follow-up of anti-transglutaminase autoantibodies among celiac children on gluten-free diet: comparison of IgG and IgA. Autoimmunity 40:117–121PubMedCrossRef
16.
go back to reference National Institutes of Health (2005) Consensus Development Conference Statement on Celiac Disease. Gastroenterology 128:S1–S9CrossRef National Institutes of Health (2005) Consensus Development Conference Statement on Celiac Disease. Gastroenterology 128:S1–S9CrossRef
18.
go back to reference Card TR, West J, Holmes GK (2004) Risk of malignancy in diagnosed coeliac disease: a 24-year prospective, population-based, cohort study. Aliment Pharmacol Ther 20:769–775PubMedCrossRef Card TR, West J, Holmes GK (2004) Risk of malignancy in diagnosed coeliac disease: a 24-year prospective, population-based, cohort study. Aliment Pharmacol Ther 20:769–775PubMedCrossRef
19.
go back to reference Freeman HJ (2004) Lymphoproliferative and intestinal malignancies in 214 patients with biopsy-defined celiac disease. J Clin Gastroenterol 38:429–434PubMedCrossRef Freeman HJ (2004) Lymphoproliferative and intestinal malignancies in 214 patients with biopsy-defined celiac disease. J Clin Gastroenterol 38:429–434PubMedCrossRef
20.
go back to reference Holmes GK, Stokes PL, Sorahan TM, Prior P, Waterhouse JA, Cooke WT (1976) Coeliac disease, gluten-free diet, and malignancy. Gut 17:612–619PubMedCrossRef Holmes GK, Stokes PL, Sorahan TM, Prior P, Waterhouse JA, Cooke WT (1976) Coeliac disease, gluten-free diet, and malignancy. Gut 17:612–619PubMedCrossRef
21.
go back to reference Goddard CJ, Gillett HR (2006) Complications of coeliac disease: are all patients at risk? Postgrad Med J 82:705–712PubMedCrossRef Goddard CJ, Gillett HR (2006) Complications of coeliac disease: are all patients at risk? Postgrad Med J 82:705–712PubMedCrossRef
Metadata
Title
Effect of a Gluten-free Diet on the Risk of Enteropathy-associated T-cell Lymphoma in Celiac Disease
Authors
Marco Silano
Umberto Volta
Alessandro De Vincenzi
Mariarita Dessì
Massimo De Vincenzi
The Collaborating Centers of the Italian Registry of the Complications of Coeliac Disease
Publication date
01-04-2008
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 4/2008
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-007-9952-8

Other articles of this Issue 4/2008

Digestive Diseases and Sciences 4/2008 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.